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INTRODUCTION  
Spinal anaesthesia is the standard technique for elective 
caesarean section worldwide. However, hypotension 
remains the main complication with this technique. The 
incidence of hypotension is more than 80% without any 
prophylactic measures. This hypotension with or without 
bradycardia has detrimental effects on both mother 
(nausea, vomiting, dyspnoea etc) and foetus (acidosis, 
neurologic injuries, etc). 
1
 
This complication can be managed by multiple approaches 
like fluid therapy, use of vesopressor or simultaneous 
administration of fluid therapy and vesopressor. 
Fluid infused before or at the time of induction of spinal 
anesthesia is referred to as “preloading” and “coloading,” 
respectively.
2 
Early reports suggested that this complication could be 
prevented by infusing a bolus of ﬂuid before induction of 
anesthesia,
 
but this strategy, along with others that increase 
central blood volume, has met with limited success.
3
  
Recently, some authors have suggested that ﬂuid 
administration should take place at the time of induction of 
anesthesia for Cesarean delivery.
3 
Among the type of fluids (crystalloid or colloid) which one 
is better, is still not known. 
Crystalloid has a short intravascular half-life because of its 
rapid distribution into the interstitial space. 
4 
In contrast to 
crystalloid, colloid remains for a longer period within the 
intravascular space.
5
  
Phenylephrine, a pure α adrenergic agonist whose action is 
to counteract the decreased systemic vascular resistance 
induced by spinal anaesthesia, without increasing the heart 
rate. It has been found to be effective when given in 
infusion. Unlike ephedrine, phenylephrine is a rapidly 
acting potent vasoconstrictor with a short duration of 
action. Phenylephrine is more effective than ephedrine seen 
in controlled clinical trial.
1
 
On this background, the study was conducted to determine 
the efficacy of crystalloid and colloid,when use as  
coloding along with vasoconstrictor-phenylephrine for the 
prevention of spinal induced hypotension. 
MATERIALS AND METHODS 
Ethical Considerations: 
The study protocol, informed consent form (in Bengali, 
Hindi & English) and case report form (CRF) were 
submitted to the ethics committee of College of Medicine 
& JNM Hospital, Kolkata West Bengal for approval. 
Subject recruitment commenced only after approval was 
obtained. Written informed consent was taken from each 
participant. Illiterate individuals gave their fingerprint (left 
thumb impression) instead of signature in the presence of 
an appropriate witness. 
Subject selection criteria:  
The subjects who had willingly participated were enrolled 
on the basis of inclusion and exclusion criteria.  
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Pregnant mothers older than 18 years, ASA (American 
Society of Anaesthesiologists) physical status I or II, 
weighing more than 50 kg and less than 90 kg, having 
uncomplicated singleton pregnancy beyond 36 weeks, 
scheduled to had elective caesarean section under spinal 
anaesthesia were eligible for this study.  
But patients who had suffering from hypertension (resting 
arterial pressure greater than 160/90 mm Hg.),had known 
coronary artery disease, cardiac valvular regurgitation and 
or stenosis, neuromuscular disorders or had a history of 
coagulation disorder or other systemic illness (renal 
disease, diabetes mellitus etc) were excluded from this 
study. 
Study Setting:  
The study was conducted in the Department of 
Anaesthesiology, College of Medicine & JNM Hospital 
(COMJNMH), Kalyani, Nadia, West Bengal.  
Screening:  
Through Obstetrics Indoor Department, COMJNMH. 
Drug dispensing:  
Gynecology Operation Theatre  
Data compilation and Statistical analysis:  
In Department of Pharmacology, COMJNMH. 
Study Design:  
The current study was designed as a prospective, 
interventional, randomized, double blind, with two parallel 
treatment groups and unicentric.   
Study period:  
The study was conducted from February 2013-April 2013. 
Regulatory Considerations: 
Since the study medication (crystalloid, colloid and 
phenylephrine) were already marketed in India at the time 
of study inception, no separate regulatory approval from 
the Drugs Controller General of India was sought. 
Study Groups and Randomization: 
A random number table generated by computer in blocks 
of 100. The large block size reduced the risk of allocation 
bias. The study coordinator was the only person with 
access to the randomization. According to the 
randomization sequence subjects fulfilling the selection 
criteria were received either crystalloid group (CR Group) 
or Colloid group (CO Group). Preprinted sheets within 
sealed sequentially numbered opaque envelopes contained 
information on group allocation. 
Blinding:  
Study was designed as double-blind study.  
METHODS 
After recruitment, a detailed medical history was taken 
followed by thorough clinical examination which included 
both general and systemic examination. After screening, 
the patients who fulfilled the selection criteria were 
randomized and allocated in either group.  
Patients received no premedication. Before spinal 
anesthesia, two 18 gauge I.V. (intravenous) catheter were 
introduced in the vein of left and right forearm of each 
patient.  
Non invasive blood pressure (BP), electrocardiography 
(ECG) and pulse oximetry were then attached for 
monitoring blood pressure (systolic, diastolic and mean 
arterial pressure), pulse rate and O2 saturation. Baseline 
measures of heart rate (HR), systolic BP (SBP), oxygen 
saturation were taken. SBP and baseline HR were taken as 
the mean of 3 readings within 10% of each other with the 
BP recorded from the dependent arm. Then, MBP (mean 
arterial blood pressure), SBP (systolic blood pressure), 
DBP (diastolic blood pressure), HR was recorded 
throughout the surgery in three minutes interval. 
 After that Patients were placed in sitting position and after 
antiseptic dressing and draping, a 25 gauge spinal needle 
was inserted in L3-4 vertebral interspace and hyperbaric 
bupivacaine 0.5%, 2.5 ml was administered intrathecally. 
Thereafter, patients were placed supine with left lateral 
uterine displacement at 15° angle. The crystalloid group 
received 15ml/kg Ringer Lactate (RL) and the colloid 
group received 7ml/kg 6% hetastarch. Each infusion was 
commenced at the time of spinal injection and completed 
within 10 minutes. No further fluid was given until after 
delivery.  The phenylephrine infusion was also started at 
the time of spinal injection at a rate of 40 mcg/min and was 
either on or off according to BP measurements determined 
at 3-minutes intervals. The infusion continued if the BP 
was at or below baseline SBP (bSBP) and turned off if 
above baseline. Two successive readings of hypotension 
(SBP - ≤80% bSBP) were treated with phenylephrine 100 
mcg from the rescue syringe. The phenylephrine infusion 
was stopped for 2 consecutive readings of bradycardia (HR 
<50 bpm) with SBP at bSBP. Atropine 0.6mg mg was 
administered for 2 consecutive readings of bradycardia. 
Motor block and the upper sensory level of anesthesia to 
light touch were also assessed. Monitoring was conducted 
before and at 3-minutes intervals throughout the surgery. 
Surgery was allowed to commence if a sensory block to 
touch at the T5 dermatome was present. No further 
assessments of block height were recorded once surgery 
commenced. Hypotensive episodes, defined as SBP <80% 
bSBP and hypertensive episodes defined as SBP ≥120% 
bSBP were recorded. The total dose of phenylephrine from 
the time of spinal injection to delivery was recorded. The 
presence of nausea and vomiting was measured on a 3-
point scale of 1, 2, and 3 indicating no nausea and no 
vomiting, nausea only, and both nausea and vomiting, 
respectively. Assessments were done at 5-minute intervals, 
until 20 minutes after the spinal injection, and when the 
parturient complained of sickness. 
STATISTICAL ANALYSIS 
Continuous data were given as mean ± standard error of 
mean (±SEM). As the continuous data were not passing the 
normality test, non-parametric statistics were performed. 
Nonparametric Mann-Whitney test was employed to find 
the significant difference (p<0.05) between the two groups 
(intergroup comparison). Friedman’s ANOVA test 
followed by Dunn’s Multiple Comparison test as post hoc 
test was employed to find the significance in the intragroup 
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in various time periods. The computer software graph pad 
instat version 3.06.was used for all the statistical analysis. 
RESULT AND ANALYSIS  
Forty subjects (40) were randomized and equally 
distributed into two groups (20 subjects in each group) 
during the period of February 2013 to April. The patient’s 
characteristics like age, weight, duration of surgery, 
baseline mean values are tabulated in table 1 and figure 1, 
2, and 3. 
  
Table 1: Shows subject characteristics and baseline values 
PARAMETERS  GROUP CO (N=20) GROUP CR (N=20)   p VALUE 
AGE  23.1 ± 0.9 29.8 ± 7.1 0.79 
WEIGHT 55.6 ± 1.2 58.3 ± 0.7 0.62 
DURATION OF SURGERY  26.3± 1.52 25.7  ± 0.8 0.73 
BASELINE HR 86.8 ± 2.78 90.7 ± 2.21 3.21 
BASELINE SBP 125 ± 2.16 122 ± 4.2 0.56 
BASELINE DBP 81.6 ± 1.75 76.3 ± 2.7 0.12 
BASELINE MBP 94 ± 2.4 89.4 ± 3.04 0.44 
BASELINE O2 
SATURATION  
98.7 ± 0.44 99.2 ± 0.134 0.48 
p value <0.05 means significant. p value from non parametric Mann-Whitney test. 
 
 
FIGURE 1: Shows age distribution in the study groups 
 
FIGURE 2: Shows distribution of weight between two 
groups 
 
 
FIGURE 3: Shows duration of surgery between two 
groups 
TOTAL REQUIREMENT OF PHENYLEPHRINE 
The phenylephrine was infused throughout the operation at 
the rate of 40 mcg/minute. No rescue medication was 
needed in any subject. Table 2 and figure 4 show the 
requirement of phenylephrine. 
TABLE 2: Shows total requirement of phenylephrine in both groups 
PARAMETER GROUP CO (N=20) GROUP CR (N=20) p VALUE 
PHENYLEPHRINE (mcg) 1052 ± 61.11 1028 ± 32.13 0.44 
p value >0.05 means non significant. p value from non parametric Mann-Whitney test. 
 
AGE DISTRIBUTION 
GROUP CO
GROUP CR
WEIGHT 
GROUP CO
GROUP CR
DURATION OF SURGERY 
GROUP CO
GROUP CR
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FIGURE 4: Total requirement of phenylephrine (in mcg) in two groups 
HEART RATE (HR): 
Heart rate was taken at baseline (HR1), then throughout the surgery in 3 minutes interval. Table 3 and figure 5 shows the 
comparison of the HR (beats/min) between two groups. 
TABLE 3: Comparison of heart rate (beats/min) in intraoperative period in two groups 
HEART RATE GROUP CO (N=20) GROUP CR (N=20) p VALUE 
H1 86.8 ± 2.78 90.7 ± 2.21 0.32 
H2 82.72 ± 3.86 96  ± 4.68 0.37 
H3 92.45 ± 5.18 91.8  ± 5.3 0.17 
H4 84.72 ± 3.67 85  ± 4.36 0.54 
H5 90.9 ± 3.99 81.6  ± 5.3 0.64 
H6 92.7 ± 4.39 83.1  ± 3.68 0.16 
H7 92.6 ± 3.66 88.34  ± 5.03 0.59 
H8 94 ± 3.34 93  ± 1.2 0.71 
H9 93.8 ± 2.81 94.6  ± 2.1 0.92 
p value from Nonparametric Mann-Whitney test was employed to find the significant difference (p<0.05) between the two groups, and  Friedman’s 
ANOVA test was employed to find the significance in the intra-group in various time periods. p value >0.05 means non-significant. 
 
 
FIGURE 5: Shows the heart rate of both groups in various time periods 
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SYSTOLIC BLOOD PRESSURE (SBP) 
SBP was taken at baseline (SBP1), then throughout the 
surgery in 3 minutes interval. Table 4 and figure 6 shows 
the comparison of the SBP (in mm of Hg) between two 
groups.
 
TABLE 4: Shows the comparison of SBP between two groups in various time periods 
SYSTOLIC BLOOD 
PRESSURE 
GROUP CO (N=20) 
[mm of Hg] 
GROUP CR (N=20) 
[mm of Hg] 
p VALUE 
SBP 1 125 ± 2.16 122 ± 4.2 0.56 
SBP 2 118 ± 3.9 113.7 ± 2.48 0.40 
SBP3 121.5 ± 4.15 116.3 ± 2.23 0.32 
SBP 4 115.1 ± 4.08 114.6 ± 2.32 0.96 
SBP 5 114.4 ± 4.39 114.3 ± 3.58 0.90 
SBP 6 114.12 ± 3.54 111.2 ± 2.92 0.71 
SBP 7 115.34 ± 3.37 108.85 ± 3.12 0.24 
SBP 8 110.89 ± 3.93 112 ± 3.05 0.64 
SBP 9 109.8 ± 4.46 115.34 ± 2.90 0.39 
p value from Nonparametric Mann-Whitney test was employed to find the significant difference (p<0.05) between the two groups, and  Friedman’s 
ANOVA test was employed to find the significance in the intra-group in various time periods. p value >0.05 means non significant. 
 
 
FIGURE 6: Shows the SBP (in mm of Hg) of both groups in various time periods 
DIASTOLIC BLOOD PRESSURE (SBP) 
DBP was taken at baseline (DBP1), then throughout the 
surgery in 3 minutes interval. Table 5 and figure 7 shows 
the comparison of the DBP (in mm of Hg) between two 
groups.
 
TABLE 5: Shows the comparison of DBP between two groups in various time periods. 
SYSTOLIC BLOOD PRESSURE  GROUP CO (N=20) GROUP CR (N=20) p VALUE 
SBP 1 81.6 ± 1.75 76.3 ± 2.72 0.12 
SBP 2 78.6 ± 2.8 73 ± 2.60 0.17 
SBP3 75.8 ± 2.49 70 ± 2.13 0.05 
SBP 4 67.6 ± 3.0 67.2 ± 2.96 0.82 
SBP 5 70.1 ± 3.17 66.7 ± 3.04 0.64 
SBP 6 69.89 ± 3.34 67.5 ± 2.67 0.65 
SBP 7 70.23 ± 3.15 61.85 ± 3.45 0.1 
SBP 8 67.89 ± 4.45 62.67 ± 6.36 0.51 
SBP 9 64.2 ± 6.19 69.67 ± 1.20 0.98 
p value from Nonparametric Mann-Whitney test was employed to find the significant difference (p<0.05) between the two groups, and  Friedman’s 
ANOVA test was employed to find the significance in the intra-group in various time periods. p value >0.05 means non significant. 
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FIGURE 7: Shows the DBP (in mm of Hg) of both groups in various time periods 
MEAN BLOOD PRESSURE (MBP) 
MBP was taken at baseline (MBP1), then throughout the 
surgery in 3 minutes interval. Table 6 and figure 8 shows 
the comparison of the MBP (in mm of Hg) between two 
groups.
 
TABLE 6: Shows the comparison of MBP between two groups in various time periods 
MEAN  BLOOD PRESSURE GROUP CO (N=20) GROUP CR (N=20) P VALUE 
MBP 1 94 ± 2.4 89.4 ± 3.04 0.44 
MBP 2 91.1 ± 3.2 83.6 ± 1.88 0.08 
MBP3 89.3 ± 2.26 82.7 ± 2.64 0.1 
MBP 4 83.3 ± 3.02 82.8 ± 2.7 0.87 
MBP 5 84.6 ± 3.24 83.4 ± 2.68 0.84 
MBP 6 84.56 ± 3.01 83 ± 2.68 0.9 
MBP 7 85.12 ± 3.12 72.84 ± 3.63 0.05 
MBP 8 82.12 ± 4.19 72 ± 8 0.4 
MBP 9 80 ± 5.72 72 ± 5.2 0.57 
p value from Nonparametric Mann-Whitney test was employed to find the significant difference (p<0.05) between the two groups, and  Friedman’s 
ANOVA test was employed to find the significance in the intra-group in various time periods. p value >0.05 means non significant. 
 
FIGURE 8: Shows the MBP (in mm of Hg) of both groups in various time periods 
OXIGEN SATURATION (%) 
Oxygen saturation was taken at baseline (OX1), then 
throughout the surgery in 3 minutes interval. Table 7 
shows the comparison of the oxygen saturation between 
two groups in various time periods. 
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TABLE 7: Shows the oxygen saturation between two groups in various time periods 
OXIGEN SATURATION GROUP CO (N=20) GROUP CR (N=20) p VALUE 
OX 1 98.7 ± 0.44 99.2 ± 0.13 0.42 
OX2 99 ± 0.21 99.5 ± 0.16 0.09 
OX3 98.6 ± 0.4 99.5 ± 0.16 0.06 
OX4 99.3 ± 0.3 99.5 ± 0.16 0.7 
OX5 98.8 ± 0.29 99.5 ± 0.22 0.3 
OX6 98.88 ± 0.4 99.6 ± 0.16 0.12 
OX7 98.88 ± 0.4 99.42 ± 0.29 0.28 
OX8 98.75 ± 0.41 99.5 ± 0.28 0.3 
OX9 99 ± 0.54 99.8 ± 0.21 0.31 
 
p value from Nonparametric Mann-Whitney test was 
employed to find the significant difference (p<0.05) 
between the two groups, and  Friedman’s ANOVA test was 
employed to find the significance in the intra-group in 
various time periods. p value >0.05 means non significant. 
ADVERSE EVENTS  
Patients had no episode of hypotension or hypertension 
during the operation. There was no single episode of ECG 
abnormality. There was no complaining of nausea or 
vomiting by any subject during the study period. 
DISCUSSION 
Although spinal anaesthesia is the standard technique for 
elective caesarean section but hypotension (incidence 80%) 
remains the main complication without any prophylactic 
measures. This hypotension has detrimental effects on both 
mother and foetus.
1 
Fluid therapy is a prophylactic measure for prevention of 
spinal anaesthesia induced hypotension. Unfortunately, no 
fluid regimen alone has proven to be effective enough for 
preventing hypotension associated with spinal anesthesia 
during cesarean delivery.
6
  
In a study, it was seen that there was no difference in the 
incidence of hypotension in women who received colloid 
administration before the initiation of spinal anesthesia 
compared with at the time of initiation of anesthesia. Both 
modalities are inefficient as single interventions to prevent 
hypotension.
6
 
Another study suggested that applying fluid loading at the 
time of administering the intrathecal local anaesthesia 
(coload) may be more rational approach for the prevention 
of post spinal hypotension. Coload might be more 
physiologically more appropriate because maximal effect 
can be achieved during the time of the block.
7 
A randomized controlled study has shown that combining a 
phenylephrine infusion with a crystalloid coload, during 
spinal anesthesia for elective cesarean delivery, 
dramatically reduces hypotension compared with no 
coload.
2
 
In several study it was found that preloading of colloid is 
much more effective than preloading of crystalloid for the 
prevention of spinal anesthesia induced hypotension. 
8,9
  
In our study we went to find out the role of colloid and 
crystalloid fluid therapy as coload in the presence of 
vasopressor phenylephrine for the prevension of spinal 
anesthesia induced hypotension during elective cesarean 
section. 
40 subjects were randomly allocated into two groups and 
after completion of 40 subjects we found that there were 
comparable demographic profiles like age, weight and 
there were no statistical differences between baseline 
parameters of both groups. 
Total requirement of phenylephrine in both Group CO and 
Group CR were comparable. Statistical analysis was done 
by non parametric Mann-Whitney test (p value 0.44). 
The HR, SBP, DBP, MBP, and Oxygen saturation all are 
comparable within group (intra-group) in various time 
periods when analysed by nonparametric Friedman’s 
ANOVA. All the parameters were also comparable 
between the groups when analysed by Nonparametric 
Mann-Whitney test. 
There was no single episode of hypotension in any group, 
so there was no requirement of rescue medication. 
This result collaborate with a randomized controlled trial 
(RCT), where it was found that no advantage in using 
colloid over crystalloid when used in combination with a 
phenylephrine infusion during spinal anesthesia for 
elective cesarean delivery. 
2
 
The main limitation of this study was that, there was 
absence of placebo group, so that it is impossible to 
determine absolute level of efficacy.  
CONCLUSION 
To conclude, there are no differences of efficacy between 
colloid and crystalloid, when use as coloading, in the 
presence of phenylephrine infusion, for the prevention of 
spinal anaesthesia induced hypotension in elective cesarean 
section.
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